MedTrace Logo

Trial of Venovenous ECMO to De-Sedate, Extubate and Mobilise in Hypoxic Respiratory Failure

NCT05562505 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 140

Last updated 2024-08-09

No results posted yet for this study

Summary

To determine whether a strategy of adding venovenous ECMO to mechanical ventilation, as compared to mechanical ventilation alone, increases the number of intensive care free days at day 60, in patients with moderate to severe acute hypoxic respiratory failure.

Conditions

  • Mechanical Ventilation Complication
  • Hypoxemia
  • Acute Respiratory Distress Syndrome Due to COVID-19
  • COVID-19 Respiratory Infection
  • Pneumonia
  • Extracorporeal Membrane Oxygenation

Interventions

OTHER

Venovenous ECMO

ECMO therapy for patients with hypoxic respiratory failure.

Sponsors & Collaborators

  • The Alfred

    collaborator OTHER

  • Australian and New Zealand Intensive Care Research Centre

    lead OTHER

Principal Investigators

  • Aidan Burrell, MBBS · Monash University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-11-28
Primary Completion
2026-07-31
Completion
2027-01-31

Countries

  • Australia
  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05562505 on ClinicalTrials.gov